Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT

Can-Fite BioPharma (CANF) Net Cash Flow (2013)

Updated

Can-Fite BioPharma's Net Cash Flow came in at $693,000 for FY2025, up 21.8% from $569,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Net Cash Flow (2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Net Cash Flow data covers 11 years.

  • Net Cash Flow carries a five-year compound annual growth rate of -34.1% (FY2020 to FY2025).
  • The five-year range for annual Net Cash Flow is -$3.91 million (FY2021) to $1.2 million (FY2023).
  • Per Business Quant, earlier years put Net Cash Flow at $569,000 in FY2024 (-52.7%), $1.2 million in FY2023, -$1.3 million in FY2022 and -$3.91 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -1.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -2.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.62 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -4.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 652.90 Mn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -1.70 Mn
API Access

Can-Fite BioPharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=CANF&period=max&api_key=YOUR_API_KEY